With World Heart Day fast approaching, let us rethink the way we treat heart disease. Let us shift our focus from late-stage treatment to prevention. By catching heart disease at its earliest stage, we can reduce suffering, increase lifespan, and decrease the burden on our healthcare system. Here’s how.
Introduction
Heart disease remains the leading cause of death worldwide, and its burden is expected to grow as populations age. Traditionally, medical care has focused on treating heart attacks, strokes, and advanced disease. However, emerging insights suggest that we may be intervening too late. A more effective and sustainable approach lies in preventing the earliest stages of disease—specifically, the development of atheroma (fatty plaque) in blood vessels.
This article explores a shift in thinking:
From reacting to cardiovascular disease to preventing it at its very origin.
Understanding Atheroma: The Silent Beginning
Atheroma refers to the buildup of cholesterol-rich plaques within the walls of arteries. This process, known as atherosclerosis, begins silently—often decades before symptoms such as chest pain or stroke occur. Atheroma represents the structural substrate of atherosclerotic cardiovascular disease or ASCVD.
The Problem with Current Approaches
Current prevention strategies rely heavily on identifying and managing risk factors such as high cholesterol, high blood pressure, diabetes, and smoking. While important, these factors do not always accurately predict who will develop heart disease.
This gap highlights a key limitation: We are estimating risk rather than detecting disease.
A New Approach: Detecting Disease Early
The proposed strategy focuses on identifying atheroma before symptoms appear. Instead of waiting for the disease to manifest, clinicians can use imaging tools to detect early plaque buildup.
Common tools include:
– Coronary artery calcium (CAC) scoring
– Other imaging techniques to visualize early plaque individualized to a patient
This represents a move toward precision prevention—treating individuals based on actual disease presence rather than predicted risk.
Why Early Intervention Matters
Atherosclerosis begins early in life and progresses slowly. By the time symptoms occur, significant and often irreversible damage has already taken place.
Early intervention offers:
– Greater potential to halt or reverse disease progression
– Reduced risk of heart attack and stroke
– Improved quality of life over decades
Treatment Implications
If early plaque is detected, treatment can begin sooner and be more targeted.
Possible interventions include:
– Lifestyle modifications (diet, exercise, smoking cessation)
– Cholesterol-lowering medications such as statins, ezetimibe, bempedoic acid, PCSK9-inhibiting monoclonal antibodies, and small interfering RNAs targeting LDL receptors
The goal shifts from managing risk to modifying disease directly.
Cost and Public Health Impact
Preventing heart disease at an early stage is not only medically beneficial but also economically sound.
– Treating advanced disease is costly
– Early prevention reduces hospitalizations and disability
– Resources can be better allocated when treatment is targeted
Conclusion
The future of cardiovascular health lies in shifting from late-stage treatment to early prevention. By focusing on the earliest signs of disease—atheroma—we can reduce suffering, extend healthy lifespan, and create a more efficient healthcare system.
Don’t wait for symptoms. Prevent the disease before it begins.
The earlier, the better.
Dr. S. Booma
Associate Consultant Cardiology,
Kauvery Hospital, Chennai
